Fingerprint
Dive into the research topics of 'Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial
Preetesh Jain, Michael Keating, Sarah Renner, Charles Cleeland, Huang Xuelin, Graciela Nogueras Gonzalez, David Harris, Ping Li, Zhiming Liu, Ivo Veletic, Uri Rozovski, Nitin Jain, Phillip Thompson, Prithviraj Bose, Courtney DiNardo, Alessandra Ferrajoli, Susan O'Brien, Jan Burger, William Wierda, Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations